Entity Common Stock, Shares Outstanding of Insight Molecular Diagnostics Inc. from 09 May 2016 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Insight Molecular Diagnostics Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 May 2016 to 03 Nov 2025.
  • Insight Molecular Diagnostics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 28,664,437, a 70% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 28,664,437 +11,829,190 +70% 03 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 28,619,749 +15,251,362 +114% 04 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 28,599,285 +20,326,212 +246% 17 Mar 2025 10-K 24 Mar 2025 2024 FY
Q3 2024 16,835,247 +8,574,485 +104% 05 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 13,368,387 +5,127,459 +62% 01 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 8,273,073 -111,005,748 -93% 03 Apr 2024 10-K 16 Apr 2024 2023 FY
Q3 2023 8,260,762 -110,383,059 -93% 02 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 8,240,928 -110,367,893 -93% 03 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 119,278,821 +765,800 +0.65% 05 Apr 2023 10-K 12 Apr 2023 2022 FY
Q3 2022 118,643,821 +26,412,384 +29% 03 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 118,608,821 +27,027,040 +30% 03 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 118,513,021 +29,598,877 +33% 25 Apr 2022 10-K/A 02 May 2022 2021 FY
Q3 2021 92,231,437 +24,980,798 +37% 02 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 91,581,781 +24,331,142 +36% 02 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 88,914,144 +26,443,022 +42% 09 Mar 2021 10-K 19 Mar 2021 2020 FY
Q3 2020 67,250,639 +15,277,809 +29% 06 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 67,250,639 +15,277,809 +29% 20 Jul 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 62,471,122 +10,498,292 +20% 04 Mar 2020 10-K 26 Mar 2020 2019 FY
Q3 2019 51,972,830 +11,308,334 +28% 29 Oct 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 51,972,830 +11,308,334 +28% 31 Jul 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 51,972,830 +20,504,272 +65% 04 Mar 2019 10-K 01 Apr 2019 2018 FY
Q3 2018 40,664,496 +9,237,429 +29% 01 Nov 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 40,664,496 +9,328,009 +30% 08 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 31,468,558 +2,100,060 +7.2% 20 Mar 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 31,427,067 +2,717,719 +9.5% 01 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 31,336,487 +5,905,313 +23% 07 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 29,368,498 +3,937,324 +15% 16 Apr 2017 10-Q 28 Apr 2017 2017 Q1
Q3 2016 28,709,348 27 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 25,431,174 10 Aug 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 25,431,174 09 May 2016 10-Q 16 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.